Singapore · Funded startup

Who invested in Cerecin

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 15 Nov 2026

$50Mraised across 1 round since 2018, from 1 source

Latest round
Round, $50MOct 2018
Investors
0
See who backed them

The rounds

  1. Oct 2018
    Round$50M

    No investor was named in the report.

    Reported by FinSMEs

Founders and team

From Cerecin's own website: 4 on the team.

  • Julie LiuVice President of R&D and CMC
  • Charles StaceyMD President & CEO
  • Lars NellemanChief Medical Officer
  • Lilian ChowChief Operating Officer

AdvisersDr. Bruno VellasProfessor Peter Goadsby

Quick answers about Cerecin

How much has Cerecin raised?

Cerecin has raised $50M across 1 round since 2018.

When did Cerecin last raise?

Cerecin's most recent round was an Undisclosed round of $50M in Oct 2018.

What was Cerecin's biggest round?

Its most recent round, $50M in Oct 2018, is also its largest on record.

What stage is Cerecin at?

Cerecin's latest named round is an Undisclosed round, in Oct 2018.

Where is Cerecin based?

Cerecin is based in Singapore.

Companies like Cerecin

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.